NA
ALT icon

NewEdge Advisors’s Altimmune ALT Stock Holding History

NewEdge Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.82K Hold
1,888
– – ﹤0.01% 3542
2025
Q4 		$6.82K Sell
1,888
-1,300
-41% -$5.67K ﹤0.01% 3585
2025
Q3 		$12K Sell
3,188
-300
-9% -$1.16K ﹤0.01% 3277
2025
Q2 		$13.5K Sell
3,488
-21,271
-86% -$115K ﹤0.01% 3095
2025
Q1 		$124K Sell
24,759
-366
-1% -$2.32K ﹤0.01% 2228
2024
Q4 		$181K Buy
25,125
+579
+2% +$4.42K ﹤0.01% 2110
2024
Q3 		$151K Buy
24,546
+1,614
+7% +$10.9K ﹤0.01% 2067
2024
Q2 		$152K Sell
22,932
-18,518
-45% -$137K ﹤0.01% 1990
2024
Q1 		$422K Buy
41,450
+31,450
+315% +$320K ﹤0.01% 1442
2023
Q4 		$113K Buy
+10,000
New +$41.8K ﹤0.01% 1904

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

NewEdge Advisors's ALT Position: Q1 2026 in Review

NewEdge Advisors held its Altimmune (ALT) position steady in Q1 2026 at 1,888 shares worth $5.82K. The position accounts for ﹤0.01% of the portfolio, ranked #3542.

NewEdge Advisors first reported a position in ALT in Q4 2023 and has held it in 10 quarters since. The position peaked at $422K in Q1 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • NewEdge Advisors held 1,888 shares of Altimmune worth $5.82K as of Q1 2026.
  • NewEdge Advisors left its Altimmune share count unchanged in Q1 2026.
  • Altimmune made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #3542 holding.
  • NewEdge Advisors first reported a position in Altimmune in Q4 2023 and has held it in 10 quarters since.
  • NewEdge Advisors's Altimmune position peaked at $422K in Q1 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.